V
Last Price
52 Week Range
- - -
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | - |
EV | - |
Shares Outstanding | - |
Beta | - |
Industry | - |
Analyst Rating | OUTPERFORM |
Analyst Target Price | |
Number of Analysts | 1 |
P/E E | - |
P/Revenue E | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin E | - |
Net Profit Margin E | - |
ROE E | - |
ROCE | - |
DPS E | - |
Payout Ratio E | - |
Div. Yield E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
V
VMED O2 UK Financing I PLC
VMED
Sector
Industry
CEO
Data Unavailable
Employees
11
Website
Data UnavailableIPO Date
Headquarters
500 Brook Drive, Reading, Berkshire, RG2 6UU United Kingdom
Review the recent VMED stock performance trends:Past 3 Months: The stock has +7.66%. Last updated: December 31, 2025 at 11:43 PM Eastern Time
Based on current VMED analyst forecasts and market assumptions, the consensus price target for VMED O2 UK Financing I (VMED) is 10.00 for 2027. Price targets reflect forward-looking estimates based on information available at the time and are inherently subject to change as underlying assumptions, company fundamentals, or market conditions evolve. Last updated:
VMED O2 UK Financing I (VMED) does not currently pay a dividend. Over the last twelve months (LTM), the company paid undefined0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future.
Analyst assessments of whether VMED O2 UK Financing I (VMED) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Consensus price target: 10.00 An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice.
Based on the latest available analyst coverage, VMED O2 UK Financing I (VMED) currently carries a Outperform consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice.
Like other publicly traded stocks, VMED O2 UK Financing I (VMED) shares are bought and sold on stock exchanges such as DB and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for VMED O2 UK Financing I (VMED) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add VMED to your watchlist.
VMED O2 UK Financing I trades under the ticker symbol VMED on the DB stock exchange. The ticker VMED is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
As of the most recently reported period, VMED O2 UK Financing I (VMED) employs approximately 11 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: December 31, 2025 at 11:43 PM Eastern Time
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.